Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients
- 1 October 2016
- journal article
- research article
- Published by Mary Ann Liebert Inc in Surgical Infections
- Vol. 17 (5), 589-595
- https://doi.org/10.1089/sur.2015.222
Abstract
Background: Interventions to contain two multi-drug-resistant Acinetobacter (MDRA) outbreaks reduced the incidence of multi-drug-resistant (MDR) organisms, specifically methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and Clostridium difficile in the general surgery intensive care unit (ICU) of our hospital. We therefore conducted a cost-effective analysis of a proactive model infection-control program to reduce transmission of MDR organisms based on the practices used to control the MDRA outbreak. Methods: We created a model of a proactive infection control program based on the 2011 MDRA outbreak response. We built a decision analysis model and performed univariable and probabilistic sensitivity analyses to evaluate the cost-effectiveness of the proposed program compared with standard infection control practices to reduce transmission of these MDR organisms. Results: The cost of a proactive infection control program would be $68,509 per year. The incremental cost-effectiveness ratio (ICER) was calculated to be $3,804 per aversion of transmission of MDR organisms in a one-year period compared with standard infection control. On the basis of probabilistic sensitivity analysis, a willingness-to-pay (WTP) threshold of $14,000 per transmission averted would have a 42% probability of being cost-effective, rising to 100% at $22,000 per transmission averted. Conclusions: This analysis gives an estimated ICER for implementing a proactive program to prevent transmission of MDR organisms in the general surgery ICU. To better understand the causal relations between the critical steps in the program and the rate reductions, a randomized study of a package of interventions to prevent healthcare-associated infections should be considered.Keywords
This publication has 25 references indexed in Scilit:
- Differential Impact of Infection Control Strategies on Rates of Resistant Hospital-Acquired Pathogens in Critically Ill Surgical PatientsSurgical Infections, 2014
- Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closureJournal of Hospital Infection, 2012
- Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unitMedecine Et Maladies Infectieuses, 2011
- Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreakJournal of Hospital Infection, 2011
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2010
- Clinical and Economic Impact of Multidrug Resistance in Nosocomial Acinetobacter baumannii BacteremiaInfection Control & Hospital Epidemiology, 2007
- Overview of Nosocomial Infections Caused by Gram-Negative BacilliClinical Infectious Diseases, 2005
- Transfer of Vancomycin-Resistant Enterococci via Health Care Worker HandsArchives of Internal Medicine, 2005
- The Impact of Antimicrobial Resistance on Health and Economic OutcomesClinical Infectious Diseases, 2003
- AcinetobacterOutbreaks, 1977–2000Infection Control & Hospital Epidemiology, 2003